Anticipatory prescribing of injectable medications for adults at the end of life in the community: A systematic literature review and narrative synthesis.
View / Open Files
Publication Date
2019-02Journal Title
Palliat Med
ISSN
0269-2163
Publisher
SAGE Publications
Volume
33
Issue
2
Pages
160-177
Language
eng
Type
Article
This Version
VoR
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Bowers, B., Ryan, R., Kuhn, I., & Barclay, S. (2019). Anticipatory prescribing of injectable medications for adults at the end of life in the community: A systematic literature review and narrative synthesis.. Palliat Med, 33 (2), 160-177. https://doi.org/10.1177/0269216318815796
Abstract
BACKGROUND:: The anticipatory prescribing of injectable medications to provide end-of-life symptom relief is an established community practice in a number of countries. The evidence base to support this practice is unclear. AIM:: To review the published evidence concerning anticipatory prescribing of injectable medications for adults at the end of life in the community. DESIGN:: Systematic review and narrative synthesis. Registered in PROSPERO: CRD42016052108, on 15 December 2016 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=52108). DATA SOURCES:: Medline, CINAHL, Embase, PsycINFO, Web of Science, Cochrane Library, King’s Fund, Social Care Online, and Health Management Information Consortium databases were searched up to May 2017, alongside reference, citation, and journal hand searches. Included papers presented empirical research on the anticipatory prescribing of injectable medications for symptom control in adults at the end of life. Research quality was appraised using Gough’s ‘Weight of Evidence’ framework. RESULTS:: The search yielded 5099 papers, of which 34 were included in the synthesis. Healthcare professionals believe anticipatory prescribing provides reassurance, effective symptom control, and helps to prevent crisis hospital admissions. The attitudes of patients towards anticipatory prescribing remain unknown. It is a low-cost intervention, but there is inadequate evidence to draw conclusions about its impact on symptom control and comfort or crisis hospital admissions. CONCLUSION:: Current anticipatory prescribing practice and policy is based on an inadequate evidence base. The views and experiences of patients and their family carers towards anticipatory prescribing need urgent investigation. Further research is needed to investigate the impact of anticipatory prescribing on patients’ symptoms and comfort, patient safety, and hospital admissions.
Keywords
Anticipatory prescribing, death, palliative care, palliative medicine, palliative medicine kit, review, systematic review, terminal care, Adult, Aged, Aged, 80 and over, Cohort Studies, Drug Prescriptions, Female, Humans, Injections, Male, Middle Aged, Palliative Care, Pilot Projects, Prescription Drugs, Qualitative Research, Retrospective Studies, Terminal Care
Sponsorship
Ben Bowers and Dr Stephen Barclay are funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East of England. Dr Richella Ryan is funded by the Eastern Deanery of the National Health Service.
Identifiers
External DOI: https://doi.org/10.1177/0269216318815796
This record's URL: https://www.repository.cam.ac.uk/handle/1810/286719
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk